drugset / Trial / NCT00835874
Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-07
- Completion
- 2009-07
Outcome
Missed primary endpoint
Stopped (Enrollment): “Difficulty in recruitment. Mothers of infants preferred to take probiotics bought over-the-counter over the possibility of being in a placebo group”
paper The overall incidence of Bell stage II to III NEC was 12%, with an incidence of 4% in the infants of the probiotic group and 18.2% in the placebo group (p = 0.12), respectively. PMID 23934538 ↗
paper Sepsis and mortality rates were similar. PMID 23934538 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bifidobacteria lactis | Other / unclassified | — | Oral |
| Subject | Lactobacillus acidophilus | Other / unclassified | — | Oral |